dipyridamole 200mg/5ml oral
syri limited, t/a thame laboratories - dipyridamole - oral suspension - 200/5 mg/ml - dipyridamole
ondansetron 4mg/5ml syrup
syri limited, t/a thame laboratories - ondansetron hydrochloride dihydrate - oral solution - 4/5 milligram(s)/millilitre - serotonin (5ht3) antagonists; ondansetron
aciclovir
syri limited, t/a thame laboratories - aciclovir - oral suspension - 400/5 mg/ml - aciclovir
amlodipine thame 10mg/5ml oral solution
syri pharma limited t/a thame laboratories - amlodipine besilate - oral solution - 10 mg/5ml - dihydropyridine derivatives; amlodipine
amlodipine thame 5mg/5ml oral solution
syri pharma limited t/a thame laboratories - amlodipine besilate - oral solution - 5 mg/5ml - amlodipine
clobazam thame 10mg/5ml oral suspension
syri pharma limited t/a thame laboratories - clobazam - oral suspension - 10 mg/5ml - benzodiazepine derivatives; clobazam
clobazam thame 5mg/5ml oral suspension
syri pharma limited t/a thame laboratories - clobazam - oral suspension - 5 mg/5ml - benzodiazepine derivatives; clobazam
amitriptyline hydrochloride 25mg/5ml oral solution
syri limited - amitriptyline hydrochloride - oral solution - 25mg/5ml - antidepressants - it is indicated for the treatment of: symptoms of depression (especially where sedation is required). nocturnal enuresis where organic pathology is excluded.
amitriptyline hydrochloride 50mg/5ml oral solution
syri limited - amitriptyline hydrochloride - oral solution - 50mg/5ml - antidepressants - it is indicated for the treatment of: symptoms of depression (especially where sedation is required). nocturnal enuresis where organic pathology is excluded.
ondansetron 4mg/5ml syrup
syri limited - ondansetron hydrochloride dihydrate - syrup - 4mg/5ml - antiemetics and antinauseants, serotonin (5ht3) antagonist - ondansetron syrup is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. ondansetron syrup is also indicated for the prevention of post-operative nausea and vomiting (ponv).